Stock Rating Upgrade
The Value Trend Rating for Vanda Pharmaceuticals Inc (NASDAQ: VNDA) improved in recent days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
On 3/21/25, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock declined by -3.0%, closing at $4.77. Trading volume in this decline was normal. Relative to the market the stock has been weak over the last nine months and has declined -3.0% during the last week.
Current PriceTarget Research Rating
Vanda Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Vanda Pharmaceuticals has a slightly positive Appreciation Score of 69 but a poor Power Rating of 21, triggering the Low Neutral Value Trend Rating.
Be the first to comment